CANF — CAN FITE BIOFARMA LTD
As of Q2 2026, 3 SEC-registered investment managers reported holding CANF (CAN FITE BIOFARMA LTD) in their latest 13F filings, with a combined reported value of $96.80K across 32.59K shares. That is -22.2% by share count (-9.32K shares) versus the previous quarter, while reported value moved -25.5%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 2 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
CANF is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Renaissance Technologies history | Q3 2021 | 93.41K | $155.00K | 0.00% | New |
| Citadel Advisors history | Q2 2026 | 32.53K | $96.62K | 0.00% | Reduce |
| Citigroup Inc history | Q1 2026 | 5.48K | $16.99K | 0.00% | New |
| UBS Group AG history | Q1 2026 | 2.15K | $6.67K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q3 2023 | 460 | $1.22K | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 59 | $175 | 0.00% | Reduce |
| Bank of America Corp history | Q2 2025 | 6 | $6 | 0.00% | New |
| Morgan Stanley history | Q2 2026 | 1 | $3 | 0.00% | Hold |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
- Citigroup Inc sold 5.48K sh · $16.99K
- UBS Group AG sold 2.15K sh · $6.67K
Fund Position History — shares by quarter (top 8 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Citadel Advisors | — | — | 11.33K | — | — | — | — | — | — | — | 14.17K | — | — | — | — | — | — | — | 34.15K | 32.53K |
| Wells Fargo & Co | 1.50K | 1.50K | 1.50K | — | — | — | — | — | — | — | — | — | 2.50K | 2.50K | 2.70K | 2.70K | 2.70K | 2.50K | 125 | 59 |
| Morgan Stanley | 196.68K | 238.46K | 304.18K | 338.27K | 320.18K | 304.68K | 33.41K | 33.31K | 33.01K | 46.27K | 55.81K | 67.81K | 50.66K | 32.51K | 23.21K | 9.91K | 12.55K | 33 | 1 | 1 |
| Citigroup Inc | 5.54K | 5.54K | 5.54K | 5.54K | 5.54K | 5.54K | 553 | 553 | 553 | 553 | 553 | 553 | 553 | 553 | — | — | — | — | 5.48K | — |
| UBS Group AG | — | — | 7.18K | 7.52K | 17.36K | 8.71K | 714 | — | — | — | 2.17K | — | — | — | — | 5.51K | 1.31K | 20.94K | 2.15K | — |
| JPMorgan Chase & Co | — | — | — | — | — | — | 100 | — | 460 | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | 93.41K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Bank of America Corp | — | 499 | 366 | — | — | — | — | — | — | — | — | — | — | — | — | 6 | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details